Bcl‐2, Bax and p53 expression in B‐CLL in relation to in vitro survival and clinical progression

• 22 April 1996
• journal article
• research article
• Published by Wiley in International Journal of Cancer
• Vol. 69  (2) , 114-119
• https://doi.org/10.1002/(sici)1097-0215(19960422)69:2<114::aid-ijc8>3.3.co;2-u

Abstract

Keywords

• SURVIVAL
• CLL
• ANTIBODY
• BCL
• CLINICAL PROGRESSION
• PROTEIN
• TREATMENT
• P53 EXPRESSION
• PROGRESSIVE